University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, Kerpener Str. 62, 50937 Cologne, Germany.
University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, Kerpener Str. 62, 50937 Cologne, Germany; University of Cologne, Faculty of Arts and Humanities, Department of Linguistics, IfL Phonetics, Herbert-Lewin-Str 6, 50931 Cologne, Germany.
Brain Lang. 2020 Mar;202:104724. doi: 10.1016/j.bandl.2019.104724. Epub 2019 Dec 26.
To prospectively evaluate the effect of PSA- and VIM DBS on speech in ET patients.
Leads were implanted bilaterally with contacts placed in both VIM and PSA. Thirteen patients were analyzed pre- and postoperatively. Preoperative speech of ET patients was compared to healthy controls. PSA- and VIM-DBS were evaluated in a randomized, double-blind crossover phase.
At preoperative baseline, we found reduced intelligibility. Differences in acoustic and VAS data ('ability to speak') compared to controls were gradient. Articulation rate could be predicted by disease duration. Decreased articulation rate, spirantization and voicing were found for PSA- and VIM-DBS. Targets did not differ in terms of speech deterioration.
Speech in ET patients without DBS can be impaired, dependent on patient's individual characteristics. Both PSA- and VIM-DBS affect speech in a comparable way. Thus, the PSA can be considered an alternative DBS target in ET without higher risk of dysarthria.
前瞻性评估 PSA 和 VIM-DBS 对 ET 患者言语的影响。
双侧植入导联,接触点分别置于 VIM 和 PSA。分析了 13 名患者的术前和术后情况。将 ET 患者的术前言语与健康对照组进行比较。PSA 和 VIM-DBS 在随机、双盲交叉阶段进行评估。
术前基线时,我们发现言语清晰度降低。与对照组相比,声学和 VAS 数据(“说话能力”)的差异呈梯度变化。言语清晰度可由疾病持续时间预测。在 PSA 和 VIM-DBS 时,发现发音率降低、流音化和浊音化。在言语恶化方面,靶点之间没有差异。
无 DBS 的 ET 患者的言语可能受损,取决于患者的个体特征。PSA 和 VIM-DBS 以类似的方式影响言语。因此,PSA 可以被认为是 ET 的一种替代 DBS 靶点,而不会增加构音障碍的风险。